#523 Hotcakes: Left Atrial Appendage Closure vs AC for Afib, Apixaban vs Rivaroxaban for VTE, Intensive LDL Targeting, GLP1s and Substance Use Disorders, and more

Join us as we review recent practice-changing articles on left atrial appendage closure vs AC for AFib, apixaban vs rivaroxaban for VTE, intensive LDL targeting, GLP1s and substance use disorders, and more! Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams (@PaulNWilliamz), Shani Herzig (@ShaniHerzig) Rahul Ganatra (@rbganatra), and Matt Watto (@doctorwatto).

Claim CME for this episode at curbsiders.vcuhealth.org!

Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME

Credits

• Written and Hosted by: Rahul Ganatra MD, MPH; Shani Herzig, MD, MPH; Paul Williams, MD, FACP, Matthew Watto MD, FACP
• Cover Art: Rahul Ganatra MD, MPH
• Reviewer: Emi Okamoto, MD
• Technical Production: Pod Paste
• Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP

• Intro, disclaimer
• Left atrial appendage closure vs anticoagulation in AF
• Apixaban vs rivaroxaban for VTE
• Intensive LDL targeting in ASCVD
• GLP1s and substance use disorders
• FDA approves Orforglipron
• E-cigarettes and cancer
• Early AM blood draws and sleep quality
• Outro

Sponsor: FIGS

Go to wearfigs.com to get 20% off during Nurses Week

Sponsor: Panacea Financial 

If you're about to make the leap into  residency and feeling the financial pressure of that transition, visit PanaceaFinancial.com/curbsiders today

Sponsor: MasterClass 

Right now, as a listener of this show, you get at least 15% off any annual membership at MASTERCLASS.com/CURB.